General Information of Drug Inactive Ingredient (DIG) (ID: E00049)

DIG Name
Vanillin
Synonyms
vanillin; 4-Hydroxy-3-methoxybenzaldehyde; 121-33-5; Vanillaldehyde; p-Vanillin; Vanillic aldehyde; Vanilla; Vanilline; Benzaldehyde, 4-hydroxy-3-methoxy-; Lioxin; 2-Methoxy-4-formylphenol; 3-Methoxy-4-hydroxybenzaldehyde; 4-Hydroxy-m-anisaldehyde; 4-Hydroxy-3-methoxy-benzaldehyde; Zimco; p-Hydroxy-m-methoxybenzaldehyde; Vanilin; 4-Formyl-2-methoxyphenol; Methylprotocatechuic aldehyde; Vanillin (natural); 4-Hydroxy-5-methoxybenzaldehyde; m-Anisaldehyde, 4-hydroxy-; Protocatechualdehyde, methyl-; Vanillin (NF); Protocatechualdehyde 3-methyl ether; vaniline; Vanillinum; NSC 15351; Vanillin [NF]; UNII-CHI530446X; MFCD00006942; CHEMBL13883; m-Methoxy-p-hydroxybenzaldehyde; CHEBI:18346; CHI530446X; 4-HYDROXY,3-METHOXY-BENZALDEHYDE; NCGC00091645-03; Vanillin, 99%, pure; 4-hydroxy-3-methoxybenzaldehyde (vanillin); DSSTox_CID_1969; WLN: VHR DQ CO1; DSSTox_RID_76433; DSSTox_GSID_21969; Vanillin [USAN]; Oleoresin vanilla; Vanilla oleoresin; MFCD08702848; CAS-121-33-5; FEMA No. 3107; CCRIS 2687; 86884-84-6; HSDB 1027; EINECS 204-465-2; BRN 0472792; AI3-00093; Nat.Vanillin; 3-methoxy-4-hydroxy-benzaldehyde; Vanillinisobutyrate; oleo-Resins vanilla; V55; Vanillin sodium salt; ACMC-1BURM; oleo-Resins vanilla-bean; Vanillin inclusion complex; Vanillin-[methoxy-13C]; methyl-Protocatechualdehyde; bmse000343; bmse000597; bmse010006; Methylprotcatechuic aldehyde; EC 204-465-2; SCHEMBL1213; 4-08-00-01763 (Beilstein Handbook Reference); MLS002303069; BIDD:ER0330; Vanillin, puriss., 99.5%; GTPL6412; SGCUT00016; Vanillin Melting Point Standard; 4-hydroxy 3-methoxybenzaldehyde; DTXSID0021969; Vanilla oleoresin (vanilla SPP); 3-methoxy-4-hydroxy benzaldehyde; 4-hydroxy-3-methoxy benzaldehyde; 3-methoxy-4-hydroxy benzoaldehyde; Vanillin, ReagentPlus(R), 99%; 4-hydroxy-3-(methoxy)benzaldehyde; HMS3651D20; HMS3885K07; Vanillin, >=97%, FCC, FG; 4-hydoxy-3-(methyloxy)benzaldehyde; BCP29943; HY-N0098; NSC15351; NSC48383; STR01001; to_000089; ZINC2567933; Tox21_113534; Tox21_201925; Tox21_300352; 4-hydoxy-3-(methyloxy)benz aldehyde; ANW-17588; BBL011956; BDBM50177405; NSC-15351; NSC-48383; NSC403658; s3071; SBB000108; STK199262; AKOS000118929; Tox21_113534_1; CCG-266230; CS-W020052; MCULE-1294709490; MP-2189; NSC-403658; Vanillin, tested according to Ph.Eur.; NCGC00091645-01; NCGC00091645-02; NCGC00091645-04; NCGC00091645-05; NCGC00091645-07; NCGC00254468-01; NCGC00259474-01; Vanillin, natural, >=97%, FCC, FG; AC-10370; AK-32997; AT-15565; BP-10602; NCI60_001085; SMR000156285; ST052001; SY224451; Vanillin, JIS special grade, >=98.0%; Vanillin, Vetec(TM) reagent grade, 98%; 3-Methoxy-4-hydroxybenzaldehyde (vanillin); DB-003805; AM20060497; FT-0618639; FT-0669738; FT-0675778; SW219190-1; vanillin (3-methoxy-4-hydroxy- benzaldehyde); 3450-EP2287158A1; 3450-EP2295424A1; 3450-EP2295426A1; 3450-EP2295427A1; 3450-EP2301934A1; 3450-EP2311821A1; 3450-EP2311824A1; 3450-EP2316831A1; 3450-EP2374783A1; 3450-EP2377841A1; A19444; C00755; D00091; Q33495; 132287-EP2284157A1; 132287-EP2295418A1; 4-hydroxy-3-methoxy-Benzaldehyde-5-chlorovanillin; 4-hydroxy-3-methoxybenzaldehyde (ACD/Name 4.0); AC-907/21098004; Q-100102; Vanillin, TraceCERT(R), certified reference material; F2190-0587; Vanillin, European Pharmacopoeia (EP) Reference Standard; 1-(AMINOMETHYL)-CYCLOPROPANECARBOXYLICACIDETHYLESTER; Mettler-Toledo Calibration substance ME 51143093, Vanillin; Vanillin, United States Pharmacopeia (USP) Reference Standard; NSC 15351;NSC-15351; NSC15351 pound>>4-Hydroxy-3-methoxybenzaldehyde; Vanillin, Pharmaceutical Secondary Standard; Certified Reference Material; Vanillin Melting Point Standard, United States Pharmacopeia (USP) Reference Standard; Mettler-Toledo Calibration substance ME 51143093, Vanillin, traceable to primary standards (LGC); Vanillin melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material
DIG Function
Flavoring agent
Formula
C8H8O3
Canonical SMILES
COC1=C(C=CC(=C1)C=O)O
InChI
1S/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H3
InChIKey
MWOOGOJBHIARFG-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 152.15 Topological Polar Surface Area 46.5
XlogP 1.2 Complexity 135
Heavy Atom Count 11 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

12 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetaminophen DMUIE76 Pain [MG30-MG3Z] Acetaminophen 500 mg tablet F00301
Alprazolam DMC7XDN Anxiety disorder [6B00-6B0Z] Alprazolam 0.25 mg tablet F00754
Caffeine DMKBJWP Orthostatic hypotension [BA21] Caffeine 200 mg tablet F03111
Cimetidine DMH61ZB Acid-reflux disorder [DA22] Cimetidine 400 mg tablet F04159
Clarithromycin DM4M1SG Bacterial infection [1A00-1C4Z] Clarithromycin 250 mg tablet F04445
Erythromycin DM4K7GQ Bacterial infection [1A00-1C4Z] Erythromycin 333 mg tablet F07372
Estradiol DMUNTE3 Breast cancer [2C60-2C65] Estradiol 1.25 mg tablet F07580
Potassium chloride DMMTAJC Hypokalemia [5C77] Potassium chloride 10 meq tablet F17388
Ranitidine DM0GUSX Peptic ulcer [DA61] Ranitidine 150 mg tablet F18816
Rimegepant DMHOAUG Migraine [8A80] Rimegepant eq 75mg base Orally Disintegrating tablet F23275
Stiripentol DMMSDOY Dravet syndrome [8A61.11] Stiripentol 250 mg powder F24373
Valproate DMCFE9I Epilepsy [8A60-8A68] Valproic acid 125 mg tablet F21867
------------------
⏷ Show the Full List of 12 Approved Drug(s)